1. Home
  2. NNNN vs HFRO Comparison

NNNN vs HFRO Comparison

Compare NNNN & HFRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$6.81

Market Cap

340.2M

Sector

Health Care

ML Signal

HOLD

Logo Highland Opportunities and Income Fund of Beneficial Interest

HFRO

Highland Opportunities and Income Fund of Beneficial Interest

HOLD

Current Price

$7.06

Market Cap

406.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNNN
HFRO
Founded
2021
2000
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
340.2M
406.7M
IPO Year
2023
2017

Fundamental Metrics

Financial Performance
Metric
NNNN
HFRO
Price
$6.81
$7.06
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
92.5K
128.1K
Earning Date
04-07-2026
01-01-0001
Dividend Yield
N/A
8.87%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$446.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.08
$5.47
52 Week High
$51.33
$7.69

Technical Indicators

Market Signals
Indicator
NNNN
HFRO
Relative Strength Index (RSI) 26.92 37.74
Support Level N/A $6.97
Resistance Level $12.62 $7.53
Average True Range (ATR) 1.62 0.15
MACD -0.12 -0.03
Stochastic Oscillator 3.06 3.19

Price Performance

Historical Comparison
NNNN
HFRO

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

About HFRO Highland Opportunities and Income Fund of Beneficial Interest

Highland Opportunities and Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to Income Fund seeks growth of capital along with income. It focuses on making investments in real estate securities, including Reits, secured and unsecured fixed-rate loans and corporate bonds, mezzanine securities, structured products, convertible and preferred securities and equities (public and private), and floating rate securities.

Share on Social Networks: